Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methoxyflurane for outpatient IUD insertion
ACTRN12620000810910Phase 4Completed
- Sponsor
- The Royal Women's Hospital
- Start
- Dec 2018
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of methoxyflurane in pain, sponsored by The Royal Women's Hospital. Primary endpoints: Patient-reported acceptability of methoxyflurane and Willingness to use methoxyflurane again. Started Dec 2018; status: completed.
02
Drugs
methoxyflurane
03
Conditions
pain
Beyond the preview
Go deeper on ACTRN12620000810910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12620000810910.